Treating medical data as a durable asset
- PMID: 32929286
- DOI: 10.1038/s41588-020-0698-y
Treating medical data as a durable asset
Erratum in
-
Author Correction: Treating medical data as a durable asset.Nat Genet. 2020 Dec;52(12):1433. doi: 10.1038/s41588-020-00734-6. Nat Genet. 2020. PMID: 33033385
Abstract
Access to medical data is central for conducting research on genomics. However, to tap these metadata (observable traits and phenotypes, diagnoses and medication, and labels), researchers must grapple with the complex and sensitive nature of the information. In this Perspective, we argue that, at this exciting time for genomics and artificial intelligence, several critical aspects of data generation, infrastructure and management are pillars of a modern data ecosystem. Many risks to privacy and many obstacles to medical research can be eliminated or mitigated by new secure data analytics. Finally, we discuss the potential consequences of medical data exiting the institutions and being managed by individuals. These shifts in data ownership have the potential for profound disruption and opportunity across many fields.
References
-
- Telenti, A. Machine learning to decode genomics. Clin. Chem. 66, 45–47 (2020). - PubMed
-
- Zou, J. et al. A primer on deep learning in genomics. Nat. Genet. 51, 12–18 (2019). - PubMed
-
- Morgan, E. & Prowle, M. (eds.) Financial Management and Control in Higher Education (Taylor & Francis, 2004).
-
- Krumm, N. & Hoffman, N. Practical estimation of cloud storage costs for clinical genomic data. Pr. Lab Med 21, e00168 (2020).
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Miscellaneous